Stocktoria

Adicet Bio, Inc. ACET

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-01-26

Adicet Bio, Inc. statistics & valuation

Market cap$78.2M
P / B0.5×
Return on equity-73.4%
Return on capital-71.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201720182019202020212022202320242025
Operating margin (%)
201720182019202020212022202320242025
Return on equity (%)
-33.40% -20.50% -23.90% -83.80% -62.80% -73.40% 201720182019202020212022202320242025
Shares outstanding
5.7M 28.1M 2.2M 39.7M 39.7M 43.0M 43.3M 5.5M 9.6M 201720182019202020212022202320242025
Net debt ($)
201720182019202020212022202320242025
Share buybacks ($)
201720182019202020212022202320242025
Return on assets (%)
-61.20% -8.50% -34.50% -23.80% -18.30% -21.10% -68.80% -53.20% -60.70% 201720182019202020212022202320242025
Free cash flow margin (%)
201720182019202020212022202320242025
Debt / equity (×)
201720182019202020212022202320242025
EPS ($)
-$2.00 -$1.70 -$3.31 -$21.33 -$16.95 201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-60.7%-53.2%-68.8%-21.1%-18.3%-23.8%-34.5%-8.5%-61.2%
Return on equity-73.4%-62.8%-83.8%-23.9%-20.5%-33.4%46.6%27.7%125.3%
Current ratio7.479.298.4113.2517.314.464.3219.1610.02

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.